Our future work will aim at ascertaining alterations of other immunocyte subsets in response to high-dose ascorbate therapy and gaining insights into the clinical correlation of NRF2 with SerpinG1 in patients with septic AKI. This evidence concerns the gene SERPING1 and acute kidney injury.